HCA Healthcare's (HCA) Q3 Earnings Beat Estimates, Up Y/Y

HCA Healthcare, Inc.HCA reported third-quarter 2018 adjusted earnings of $2.16 per share, surpassing the Zacks Consensus Estimate by 11.9%. Moreover, the bottom line shot up nearly 78.5% year over year. This upside was backed by higher same facility admissions.

The company's net income per share of $2.15 in the third quarter includes 1 cent gained from the sale of facilities and 2 cents from the loss on retirement of debt.

HCA Healthcare, Inc. Price, Consensus and EPS Surprise

HCA Healthcare, Inc. Price, Consensus and EPS Surprise | HCA Healthcare, Inc. Quote

Quarterly Details

HCA Healthcare generated revenues of $11.4 billion, beating the Zacks Consensus Estimate of $11.3 billion by 1.6%. The top line was up 7.1% from the year-ago period, primarily driven by higher admissions.

Same facility equivalent admissions increased 3.4% year over year while same facility admissions rose 3.1%. Same facility revenues per equivalent admission grew 3.9%.

In the third quarter, cash flow from operations totaled $1.721 billion.

Expenses increased nearly 4.7% year over year to $10.3 billion.

Adjusted EBITDA totaled $2.1 billion, up 18.0% year over year.

As of Sep 30, 2018, HCA operated 179 hospitals and around 1,800 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.

Financial Update

As of Sep 30, 2018, the company had cash and cash equivalents of about $868 million, total debt of $33.2 billion and total assets of $37.7 billion.

During the reported quarter, capital expenditures summed $880 million excluding acquisitions. Cash flows from operating activities were $1.5 billion, up 12.6% year over year.

Dividend Update

HCA Healthcare has announced a quarterly cash dividend of 35 cents per share payable Dec 28 to stockholders of record at the close of business on Dec 3, 2018.

2018 Outlook Updated

The company expects 2018 revenues in the range of $46-$47 billion, up from its prior estimate of $45.5-$46.5 billion. Moreover, it now anticipates adjusted EBIDTA to be between $8.7 and $8.9 billion, up from the prior guided range of $8.65-$8.85 billion. EPS is projected to be in the range of $9.05-$9.45, up from $9-$9.40. The company reiterates its capex view of about $3.5 billion.

Zacks Rank

HCA Healthcare carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .

Releases From the Medical Sector

UnitedHealth Group Incorporated's UNH third-quarter bottom line beat estimates on the back of higher revenues.

Centene Inc.'s CNC third-quarter earnings surpassed estimates, majorly driven by the execution of growth strategy and solid operating metrics.

Community Health Systems, Inc. CYH came up with a loss, wider than expected due to lower number of admissions in the quarter.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

HCA Healthcare, Inc. (HCA): Free Stock Analysis Report

Community Health Systems, Inc. (CYH): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics

Earnings Stocks

Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More